Strategies to establish the BE changing the physiological behavior [Study Per­for­mance]

posted by Mauricio Sampaio  – Brazil, 2016-06-29 06:47  – Posting: # 16459
Views: 3,944

Dear members...

According draft guidance on hydrocortisone (Nonbinding Recommendations on Hydrocortisone) FDA recommends a 4 mg dose of dexamethasone administered 10 hours prior to drug administration as a pre-treatment to lower endogenous hydrocortisone levels. This procedure in bioequivalence studies is normal? Can I change the phisiological behavior to measure a principal analyte in appropriate biological fluid and determine the bioequivalence between two formulations?

Can I extrapolate this idea, in bioequivalence studies, to reduce the first pass effect using the vasodilator medicines* before the administration of drugs which are highly metabolized? To have a chance to mensure the parent compound (not metabolized) and to establish the bioequivalence result ?

* The use of vasodilator medicines increase the splenic blood flow and reduce the first pass effect
.

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,874 posts in 4,214 threads, 1,366 registered users;
online 13 (0 registered, 13 guests [including 7 identified bots]).
Forum time (Europe/Vienna): 14:54 CEST

Statistics. A sort of elementary form of mathematics which consists of
adding things together and occasionally squaring them.    Stephen Senn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5